================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-------------------------
SCHEDULE 14D-9
SOLICITATION/RECOMMENDATION STATEMENT
PURSUANT TO SECTION 14(D)(4) OF THE
SECURITIES EXCHANGE ACT OF 1934
-------------------------
PATHOGENESIS CORPORATION
(Name of Subject Company)
PATHOGENESIS CORPORATION
(Name of Person Filing Statement)
-------------------------
COMMON STOCK, $0.001 PAR VALUE
(Title of Class of Securities)
-------------------------
70321E 10 4
(CUSIP Number of Class of Securities)
-------------------------
WILBUR H. GANTZ
CHAIRMAN OF THE BOARD AND CHIEF EXECUTIVE OFFICER
PATHOGENESIS CORPORATION
5215 OLD ORCHARD ROAD
SUITE 900
SKOKIE, ILLINOIS 60077
(847) 583-8050
(Name, Address and Telephone Number of Person Authorized to Receive Notice and
Communications on Behalf of the Person Filing Statement)
-------------------------
COPY TO:
DAVID M. SILK, ESQ.
WACHTELL, LIPTON, ROSEN & KATZ
51 WEST 52ND STREET
NEW YORK, NEW YORK 10019
(212) 403-1000
-------------------------
[X]CHECK THE BOX IF THE FILING RELATES SOLELY TO PRELIMINARY COMMUNICATIONS
MADE BEFORE THE COMMENCEMENT OF A TENDER OFFER
================================================================================
